Nanotechnology Now

Our NanoNews Digest Sponsors







Heifer International

Wikipedia Affiliate Button


Home > Press > Liquidia Technologies Receives Significant Equity Investment to Bolster Development of Next Generation Vaccines: Bill & Melinda Gates Foundation Invests in the Future of Global Disease Prevention

Abstract:
Liquidia Technologies today announced the Bill & Melinda Gates Foundation has made a $10 million program-related investment (PRI) in the company to support the development and commercialization of safer and more effective vaccines and therapeutics. This follows recent announcements of the first Liquidia clinical trial of its lead seasonal flu candidate (LIQ001) and a collaborative agreement with the PATH Malaria Vaccine Initiative (MVI).

Liquidia Technologies Receives Significant Equity Investment to Bolster Development of Next Generation Vaccines: Bill & Melinda Gates Foundation Invests in the Future of Global Disease Prevention

Research Triangle Park, NC | Posted on March 4th, 2011

"We are delighted the Gates Foundation has decided to join an outstanding group of investors that share our confidence in the potential of PRINT® technology to improve vaccine delivery and effectiveness," said Neal Fowler, Chief Executive Officer at Liquidia. "As the field of vaccines continues to grow, success will be defined by our ability to produce and deliver highly efficacious therapies in quantities and costs that will support the global demand."

The proprietary PRINT technology offered by Liquidia represents unprecedented control of particle size, shape, and chemistry in a highly consistent and scalable manufacturing process. This platform gives Liquidia the ability to rapidly and precisely tune these important parameters, creating the potential to advance cost-effective, potent vaccines for a variety of markets and disease targets. PRINT technology could be critical toward advancing the development of vaccines to prevent diseases, such as malaria, that primarily affect people in the developing world.

The Bill & Melinda Gates Foundation made this equity investment in Liquidia as part of an initiative that commits $400 million in program-related investments (PRIs) to deepen the impact of the foundation's work. These include the use of financial tools, such as low-interest loans, loan guarantees, and equity investments to secure financing for activities of select organizations that fall within its focus areas.

"Funding innovation is a key to addressing the unmet health needs of the world's poorest people," said Doug Holtzman, Deputy Director, for the infectious diseases team at the Bill & Melinda Gates Foundation. "This unique investment partnership will help us advance vaccine development as part of our commitment to help research, develop and deliver vaccines for the world's poorest countries."

In addition to the Gates Foundation, Liquidia was most recently supported by a strong set of Series C investors, including Canaan Partners, New Enterprise Associates, PPD Inc., Morningside Venture Investments Limited, Pappas Ventures, and Firelake Capital.

####

About Liquidia Technologies
Liquidia Technologies is developing precisely engineered particles for improved delivery of biologics and small molecules for vaccine and therapeutic applications. The ability to control particle design parameters such as size, shape and chemistry is allowing Liquidia to address critical unmet needs in the prevention and treatment of human disease. In addition to its own products, Liquidia licenses its PRINT particle technology and its GMP manufacturing capabilities to support proprietary programs advanced by collaborators. The company was founded on the discoveries of Professor Joseph DeSimone and colleagues at the University of North Carolina, Chapel Hill and is located in Research Triangle Park, North Carolina.

For more information, please click here

Contacts:
Liquidia Technologies
Michael Parks
267-885-3066

Copyright © Liquidia Technologies

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013

NanoInk, Inc. Assets To Be Sold May 18th, 2013

Beautiful "flowers" self-assemble in a beaker: Elaborate nanostructures blossom from a chemical reaction perfected at Harvard May 17th, 2013

Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013

VC/Funding/Angel financing/Loans/Leases

Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013

Nanomedicine

Nanotechnology could help fight diabetes: Injectable nanogel can monitor blood-sugar levels and secrete insulin when needed May 16th, 2013

Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013

Pitt Chemists Demonstrate Nanoscale Alloys So Bright They Could Have Potential Medical Applications: “Think about a particle that will not only help researchers detect cancer sooner but be used to treat the tumor, too.” May 15th, 2013

Using clay to grow bone: Researchers use synthetic silicate to stimulate stem cells into bone cells May 15th, 2013

Announcements

Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013

NanoInk, Inc. Assets To Be Sold May 18th, 2013

NIA Public Briefing: Nanotechnology and the Council of Europe May 17th, 2013

Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013

Grants/Awards/Scholarships/Gifts/Contests/Honors/Records

Beautiful "flowers" self-assemble in a beaker: Elaborate nanostructures blossom from a chemical reaction perfected at Harvard May 17th, 2013

Add boron for better batteries: Rice University theorists say graphene-boron mix shows promise for lithium-ion batteries May 17th, 2013

Nanotechnology Pioneer Named 'Entrepreneur of the Year': Royal Society of Chemistry honors Chad Mirkin for commercializing innovations May 10th, 2013

International Space Development Conference Highlights - Dr A.P.J. Abdul Kalam Former President of India - Winner of the 2013 Wernher von Braun Memorial Award May 8th, 2013

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More












ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project








abbigliamento uomo
Computer Accessories
© Copyright 1999-2013 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE